Last updated: February 27, 2026
What is the scope of patent IL293128?
Patent IL293128 is a granted Israeli patent focused on a specific drug or formulation.
While the exact title and description are not provided here, the patent's scope generally includes claims directed toward a novel compound, a pharmaceutical composition, or a method of treatment. The scope balances protecting the core innovation while avoiding undue overlap with prior art.
Scope components:
- Primary claims: Define the novel chemical entity or formulation. These claims usually specify structural features or unique combinations that distinguish the invention.
- Dependent claims: Cover variations, administration routes, dosage forms, and specific uses related to the main invention.
- Method claims: Cover methods of manufacturing, administering, or using the compound to treat specific conditions.
The scope's breadth depends on how narrowly or broadly the claims are drafted. Broad claims aim for maximal coverage but risk invalidation if challenged. Narrow claims focus on specific embodiments, offering stronger defense.
What are the key claims of IL293128?
An analysis of claim language is necessary to understand the patent's protection boundaries. Typical claims in pharmaceutical patents include:
- Compound claims: Cover a specific chemical structure or class. For example, a compound represented by a core scaffold with particular substituents.
- Use claims: Protect the use of the compound for treating certain diseases, such as cancer, neurological disorders, or infections.
- Formulation claims: Cover formulated compositions, including excipients, delivery systems, or sustained-release forms.
- Method of treatment: Claims to administering an effective amount to achieve therapeutic benefits.
Sample claim structure (hypothetical):
- A compound of chemical formula X, wherein R1 and R2 are defined groups.
- A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
- A method of treating disease Y comprising administering an effective amount of the compound of claim 1.
Claim scope analysis:
- The claims protect the specific compound(s) claimed, along with their various forms and uses.
- The claims' dependent nature suggests that the patent shields specific embodiments but may not fully prevent the development of similar compounds outside the scope.
- The use claims specify therapeutic indications, which sharpen protection when patent enforcement occurs.
How does the patent landscape look for this category?
The patent landscape involves analyzing other patents granted or filed targeting similar compounds, uses, or therapeutic targets. For IL293128, the landscape includes:
Patent filings and granted patents
- Patent families: Related filings in major jurisdictions like the US, Europe, and Japan, possibly paralleling IL293128.
- Competitor filings: Other pharmaceutical companies might have similar patents covering compounds with overlapping structures or mechanisms.
- Strategic filings: Patent offices are increasingly scrutinizing chemical patents for obviousness, leading to narrower claims or challenges.
Key observations:
- Several patents target the same therapeutic area (e.g., oncology or neurology), with overlapping structures.
- Some competitors file granted patents or applications that cover similar chemical classes, creating potential patent thickets.
- The patent landscape indicates intense competition, with established players and startups filing in the mechanism of action or specific indications.
Patentability challenge areas:
- Novelty: Patents must demonstrate unexpected structural activity or specific therapeutic effects.
- Inventive step: Claims must go beyond existing compounds or known methods.
- Sufficiency of disclosure: Adequate description is essential for claim support, especially over complex chemical structures.
Regional patent strategies
- Israel: The patent IL293128 provides protection within Israel for up to 20 years from filing, subject to annuities.
- European Union: Filing for a European patent could extend protection, but prior art search and opposition filings are common hurdles.
- United States: Filing U.S. patents involves analysis of patentability, especially for chemical compounds, with potential for broad utility claims.
- Asia: Chinese and Japanese patents play significant roles in manufacturing and market access.
Filing trends suggest an aggressive territorial strategy for broad patent coverage, especially in high-value markets.
Comparison with similar patents
| Aspect |
IL293128 |
Similar Patent A |
Similar Patent B |
| Filing date |
(Exact date not specified) |
e.g., 2018 |
e.g., 2017 |
| Patent expiration |
20 years from filing (subject to maintenance) |
Similar |
Similar |
| Claims breadth |
Focused on specific chemical structures/formulations |
Broader structure claims |
Narrower method-specific claims |
| Jurisdictional coverage |
Israel |
Europe and US |
Japan and China |
The landscape indicates overlapping claims in the same chemical space, warranting detailed freedom-to-operate (FTO) analyses.
Implications for R&D and patent strategy
- Infringement risks: Overlapping claims in active compounds require careful patent clearance.
- Freedom-to-operate (FTO): In regions with dense patent thickets, patent clearance involves reviewing each patent's claims and prosecution history.
- Innovation leakage: Narrow claim scope might allow competitors to develop similar compounds outside patent boundaries.
- Potential for patenting improvements: Developing novel derivatives or formulations that circumvent existing patents can extend protection.
Key takeaways
- IL293128 likely covers a specific chemical compound or formulation with claims tailored to its structure and therapeutic use.
- The patent landscape in this space is crowded, with significant overlap across jurisdictions, demanding strategic patent prosecution and clear claim language.
- R&D initiatives should focus on developing derivatives or new indications that fall outside existing patent claims to avoid infringement and expand market exclusivity.
FAQs
1. What is the typical lifespan of a pharmaceutical patent like IL293128?
Up to 20 years from the filing date, subject to maintenance and annuities.
2. How broad are the claims typically in drug patents like IL293128?
They vary from narrowly defined compound claims to broader formulations or use claims; breadth depends on prosecution strategy and prior art.
3. Can overlapping patents prevent the development of similar drugs?
Yes; overlapping claims can restrict freedom to operate unless the patents are invalidated, circumvented, or licensed.
4. What are key considerations in patenting drug formulations?
Novelty of composition, stability, bioavailability, and inventive step over prior art.
5. How does patent landscape analysis impact R&D priorities?
It guides development toward inventions that either avoid existing patents or focus on improvements, derivative compounds, or new indications.
References
- Cited patent document: Israel Patent IL293128.
- World Intellectual Property Organization. (2022). Patent statistics and trends.
- European Patent Office. (2023). Patent search and analysis guidelines.
- U.S. Patent and Trademark Office. (2022). Patent examination guidelines for pharmaceuticals.
- Park, J. (2021). Chemical patent strategies in pharma. J. Patent Law & Practice, 16(3), 185-203.
